The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
about
Hypertrophic cardiomyopathy in childhoodElectrocardiographic Changes and Arrhythmia in Fabry DiseaseCardiovascular magnetic resonance: Diagnostic utility and specific considerations in the pediatric population.Distribution of late gadolinium enhancement in various types of cardiomyopathies: Significance in differential diagnosis, clinical features and prognosisClinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathyReproducibility of Gadolinium Enhancement Patterns and Wall Thickness in Hypertrophic Cardiomyopathy.High Spatial Resolution Cardiovascular Magnetic Resonance at 7.0 Tesla in Patients with Hypertrophic Cardiomyopathy - First Experiences: Lesson Learned from 7.0 Tesla.2014 korean guidelines for appropriate utilization of cardiovascular magnetic resonance imaging: a joint report of the korean society of cardiology and the korean society of radiology.The role of magnetic resonance imaging in hypertrophic cardiomyopathy.Cardiac magnetic resonance imaging for the investigation of cardiovascular disorders. Part 1: current applications.Cardiovascular magnetic resonance imaging of myocardial infarction, viability, and cardiomyopathies.Right ventricular cardiovascular magnetic resonance imaging: normal anatomy and spectrum of pathological findings.Cardiovascular magnetic resonance in systemic hypertensionThe emerging clinical role of cardiovascular magnetic resonance imaging.Diagnostic approaches for diabetic cardiomyopathy and myocardial fibrosis.CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation.Cardiovascular magnetic resonance in the diagnosis of acute heart transplant rejection: a reviewA primer on arrhythmias in patients with hypertrophic cardiomyopathy.In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy.A novel and practical cardiovascular magnetic resonance method to quantify mitral annular excursion and recoil applied to hypertrophic cardiomyopathy.Late gadolinium enhancement does occur in Tako-tsubo cardiomyopathy - A quantitative cardiac magnetic resonance and speckle tracking strain study.Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy.High sensitivity of late gadolinium enhancement for predicting microscopic myocardial scarring in biopsied specimens in hypertrophic cardiomyopathyPatterns of late gadolinium enhancement in Duchenne muscular dystrophy carriers.Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy.Relationship of delayed enhancement by magnetic resonance to myocardial perfusion by positron emission tomography in hypertrophic cardiomyopathy.Myocardial fibrosis detected by cardiac CT predicts ventricular fibrillation/ventricular tachycardia events in patients with hypertrophic cardiomyopathy.ECG characteristics according to the presence of late gadolinium enhancement on cardiac MRI in hypertrophic cardiomyopathyIn hypertrophic cardiomyopathy reduction of relative resting myocardial blood flow is related to late enhancement, T2-signal and LV wall thickness.Myocardial fibrosis identified by cardiac magnetic resonance late gadolinium enhancement is associated with adverse ventricular mechanics and ventricular tachycardia late after Fontan operationAdministration of bleomycin via the oropharyngeal aspiration route leads to sustained lung fibrosis in mice and rats as quantified by UTE-MRI and histology.Rest perfusion abnormalities in hypertrophic cardiomyopathy: correlation with myocardial fibrosis and risk factors for sudden cardiac deathMyocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I.The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance.Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension.Low-grade inflammation and the phenotypic expression of myocardial fibrosis in hypertrophic cardiomyopathy.Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies.Myocardial scarring on cardiovascular magnetic resonance in asymptomatic or minimally symptomatic patients with "pure" apical hypertrophic cardiomyopathy.Hypertrophic cardiomyopathy: refining the lens of cardiac magnetic resonance to evaluate late gadolinium enhancement.Low MMP-8/TIMP-1 reflects left ventricle impairment in takotsubo cardiomyopathy and high TIMP-1 may help to differentiate it from acute coronary syndrome
P2860
Q24599577-F188A8AD-0052-4A46-8A67-20171FD2A74FQ26751508-5F401625-D600-4F3C-89E5-C14C299FC07EQ26767019-CD8CB2C6-6047-46DB-8D04-5159E464054DQ26864740-573E9EDA-B87C-4EF5-9DC7-1EB3487D452EQ26999424-E7924D27-D8BC-403E-9E95-73101F1FE202Q30376835-1372F7D3-40C1-459A-BC97-A405B4A4A909Q30390279-9DEF03BC-B454-4135-A30D-4F61FB1B6F98Q30423759-AC397DAE-19D3-4035-B5A5-360EA3C7116FQ30426380-0F9AB04C-D6CF-4006-B9D7-C9D04151B9A3Q30432349-FAB72347-B16D-4288-B8CE-455212A1CA7DQ30432814-5794BACF-E6D5-4A18-8345-CC1B54B1523FQ30456010-D8FD421F-DD23-45DB-A73C-6DED2D9FBE96Q30466693-6EE502A1-E027-4671-9686-4096BBB40FB4Q30475257-FBD6DDD4-756E-413D-B9FE-0358D7FB0910Q30476724-F941348A-7A45-4B15-9E5F-8400949CA17FQ30486502-90C15302-BF2D-4281-AD11-C4E3EEEE3513Q30490539-DEAA5F95-F048-4ADC-8573-8981E9B7FD09Q33161569-040E744A-3F4F-41FA-B440-00EE57604091Q33634302-C9962365-097F-4F52-803B-EE1CE210A737Q33700642-453C6201-3818-4AA4-9AEC-EBEAA1CB1A01Q33753532-15FABC1A-4146-40AC-9E4D-D97F3817AF84Q33843181-301C6699-B96D-475D-B552-FD9A29A3E7A3Q33855587-9606000A-6029-4C04-ACE7-0B5F1840D4B0Q33895261-AB66A2F6-7517-4AEE-ABDD-77F621D6DA96Q33920111-3DF1232C-908E-4049-B32D-BE1ED77050FFQ34014152-A8F5EA69-1AAA-4849-820B-8FCB291FE042Q34028344-C4927D4C-8206-4D29-8503-AD30CC222482Q34304394-1CBE5B4E-CC3D-447F-B93F-A57CC230F7C1Q34364374-C3E8F011-39EF-40EC-BD88-0FB72F23E829Q34702433-11536B8D-DFFF-425D-9FA9-C2979904C8EAQ34718159-8D1989BA-945D-484A-8FCB-B9CAF8B019D3Q35431078-D76B51AB-EFC5-4634-AA9B-AA13BF5691F9Q35584472-0856CD3A-9429-42DF-BB5E-D9F783BB66CFQ35845452-61F6B92B-1534-4943-A6EB-CAB83F1D5F04Q35848887-68C40355-C721-47FE-9CDF-BDD7A80A1396Q36011990-A2935A5E-C9C7-4195-858E-B9F46935B5F5Q36098649-FC2FB935-5101-4932-89AD-49FFDCFA5E69Q36164284-96CF3ED6-136B-4568-8294-D16FF0EF09CBQ36203626-66E0C40B-AC78-4DE9-A394-D9BEADC9663DQ36302470-A611C3A6-95E4-4D71-A70E-CF97F6E8E225
P2860
The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The histologic basis of late g ...... n hypertrophic cardiomyopathy.
@en
type
label
The histologic basis of late g ...... n hypertrophic cardiomyopathy.
@en
prefLabel
The histologic basis of late g ...... n hypertrophic cardiomyopathy.
@en
P2093
P1476
The histologic basis of late g ...... in hypertrophic cardiomyopathy
@en
P2093
Andrew G Elkington
James C C Moon
Margaret Burke
Mario Petrou
Siew Yen Ho
P304
P356
10.1016/J.JACC.2004.03.035
P407
P577
2004-06-01T00:00:00Z